Resources
Explore our growing body of resources and research from across the women’s health innovation ecosystem.
Explore
2022
A Systematic Review of Interventions that Integrate Perinatal Mental Health Care into Routine Maternal Care in Low- and Middle-Income Countries
Prom, M. C. et al.
Summarizes evidence on the effectiveness and design gaps of integrated perinatal mental health interventions in routine maternal care in low- and middle-income countries.
2024
Abnormal uterine bleeding: The well-known and the hidden face
Leal et al.
Summarizes causes, diagnosis, and management of abnormal uterine bleeding to inform clinical practice and highlight knowledge gaps.
2020
Antenatal Depression and its Association with Adverse Birth Outcomes in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis
Fekadu Dadi, A. et al.
Summarizes prevalence, risk factors, and consequences of antenatal depression in low- and middle-income countries to inform interventions and policy.
2019
Cardiovascular Disease and the Female Disadvantage
Woodward, M.
Summarizes sex differences in cardiovascular disease, highlighting female disadvantages in risk, treatment, and research, to inform improved women's health strategies.
2023
Chemo-immunotherapy: A New Trend In Cancer Treatment
Sordo-Bahamonde et al.
Reviews recent advances, mechanisms, clinical approvals, efficacy, challenges, and future directions of chemo-immunotherapy combinations for cancer treatment.
2023
Deep learning models reveal replicable, generalizable, and behaviorally relevant sex differences in human functional brain organization
Ryali et al.
Provides information on using deep learning to identify robust, replicable, and behaviorally relevant sex differences in human functional brain organization.
2022
Dementia Clinical Trials Over The Past Decade: Are Women Fairly Represented? BMJ Neurology Open.
Pinho-Gomes et al.
Reviews data on women's representation and sex-disaggregated outcomes in dementia clinical trials since 2010 to inform equity and improve research practices.
2019
Disparities in the Allocation of Research Funding to Gynecologic Cancers by Funding to Lethality Scores
Spencer, R. J. et al.
Summarizes the efficacy and safety of PARP inhibitors in ovarian cancer treatment, providing clinical trial data to guide therapeutic decision-making.
2024
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials
Verma et al.
Summarizes recent advances in cardiovascular disease management, providing clinical data and recommendations to guide evidence-based patient care decisions.
2011
Erlotinib Versus Chemotherapy as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer (Optimal, Ctong-0802): A Multicentre, Open-Label, Randomised, Phase 3 Study
Zhou, C. et al.
Reviews data on the efficacy and safety of pazopanib in advanced renal-cell carcinoma, supporting its use as a first-line treatment option.
2024
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex
Porreca et al.
Summarizes sex-specific outcomes of CGRP-targeting therapies for acute and preventive migraine treatment, highlighting differences in efficacy between men and women.
2024
Exploring the Experience of Pain and Pain Management for Pregnant and Postpartum Veterans with Chronic Musculoskeletal Pain
Kroll-Desrosiers
Summarizes experiences, barriers, and recommendations for pain management among pregnant and postpartum veterans with chronic musculoskeletal pain to inform improved VHA care.
2022
Gender Differences in Cardiometabolic Health And Disease in a Cross-Sectional Observational Obesity Study
Strack, C., et al.
Provides information on sex differences in body fat distribution and their impact on cardiometabolic risk and metabolic syndrome prevalence in obesity research.
2000
Gender Differences in Depression: Critical Review
Piccinelli, M. & Wilkinson, G.
Reviews data on gender differences in depression, examining risk factors and determinants to clarify why prevalence is higher in females than males.
2021
Gender Disparity in the Funding of Diseases by the U.S. National Institutes of Health
Mirin, A. A.
Analyzes and quantifies NIH disease funding disparities by gender, comparing allocations to disease burden to highlight inequities in research funding priorities.
2014
Gendered Medicine
Jacobson, R.
Summarizes sex differences in response to psychotropic drugs, reviewing evidence to inform safer, more effective, gender-specific medication guidelines and clinical practices.
2020
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study
Khan, M. A. et al.
Summarizes global epidemiology, trends, and forecasts of ischemic heart disease to inform health policy, prevention strategies, and future healthcare planning.
2019
Global, Regional, and National Burden of Neurological Disorders, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016
GBD 2016 Neurology Collaborators
Provides information on the global, regional, and national burden of 15 neurological disorders from 1990–2016 to inform health policy and resource allocation.
2023
Global, Regional, and National Time Trends in Incidence for Migraine, from 1990 to 2019: an Age-Period-Cohort Analysis for the GBD 2019
Fan, L. et al.
Summarizes global, regional, and national migraine incidence trends (1990-2019) using age-period-cohort analysis to inform prevention and management strategies.
2024
Immune system adaptation during gender-affirming testosterone treatment
Lakshmikanth
Provides information on immune system changes during gender-affirming testosterone therapy in trans men, aiming to clarify hormone effects on immunity and health.
2005
Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer
Singh, S. et al.
Summarizes sex-based differences in chemotherapy toxicity, response rates, and survival outcomes in small-cell lung cancer to inform treatment considerations.
2021
Market Demand for Noncommunicable Disease Drugs and Diagnostics
The Defeat-NCD Partnership
Summarizes market demand, availability, and affordability gaps for non-communicable disease drugs and diagnostics in LMICs to inform procurement and policy decisions.
2024
Mechanisms Underlying Sex Differences In Autoimmunity
Fairweather et al.
Summarizes mechanisms underlying sex differences in autoimmunity, reviewing roles of hormones, genes, environment, and emerging research on microRNAs and extracellular vesicles.
2025
Mental Health Atlas 2024
World Health Organization
Summarizes global data on countries’ mental health policies, services, workforce, and progress toward WHO mental health targets to identify gaps and guide improvements.